Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Disease Detection International

This article was originally published in The Gray Sheet

Executive Summary

Considering proposal by Irish firm Trinity Biotech to merge via a stock swap. DDI announced Jan. 17 that it had received a letter of intent from Trinity's board proposing a merger of the two companies. The proposal "contemplates an exchange of shares in which stockholders of Disease Detection International, other than Trinity, would receive American Depositary Receipts representing ordinary shares of Trinity," the release states. Trinity, which reportedly owns about 400,000 shares of DDI's common stock and all of the company's Series A preferred stock, holds a license to DDI's SeroCard diagnostic test for sexually transmitted and infectious diseases. Using the rapid test format of the SeroCard along with a saliva detection method obtained from Amsterdam-based Saliva Technologies, Trinity is developing a test to detect HIV-1 antibodies in saliva ("The Gray Sheet" April 26, 1993, I&W-4)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel